Studying inflammation in stroke to find new treatments
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial looks at how inflammation affects acute stroke and bleeding in the brain. It aims to find new targets for treatment by studying patients within hours of their symptoms starting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have had an acute ischemic stroke (blocked blood vessel) and be admitted to the hospital within 8 hours of your first symptoms.
- Your stroke must be caused by a blockage of a large or medium blood vessel in the front part of your brain, and you must have a certain level of disability (NIHSS score greater than 5).
- Or you must have had a type of bleeding stroke called aneurysmal subarachnoid hemorrhage and be admitted within 36 hours of your symptoms starting.
- You must not have had a significant disability before this stroke (modified Rankin Scale score of 0 or 1).
- If you had an ischemic stroke, you must not have bleeding inside the stroke area.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at blood “inflammation-related” biomarkers to understand what happens early after certain sudden brain events. It may help doctors predict outcomes and tailor treatment for people like those with stroke types that sometimes need a clot-removal procedure.
This study looks at how certain proteins in the blood change after a procedure to remove a large blockage in a brain artery. The goal is to better understand recovery after stroke treatment.
This trial studies how certain proteins in the blood affect brain inflammation after a small brain bleed (intracerebral hemorrhage). It aims to find new ways to reduce inflammation and improve recovery.
This trial is for people who had a brain bleed from a burst aneurysm and need intensive care. It tests better ways to diagnose and treat delayed brain injury that can happen days or weeks later.
This study looks at inflammatory cells in the blood and the blood clot removed from the brain during a stroke emergency. The goal is to better understand the role of inflammation in stroke, which could lead to improved treatments.
This trial tests whether combining local cooling with a procedure to reopen blocked arteries can help people who have had a severe stroke with a large area of brain damage. It looks at patients who can be treated within 24 hours of symptoms starting.
Hear when a new Delayed Cerebral Ischemia After Subarachnoid Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.